In FDA Hearing, Pingree Presses Commissioner on COVID Vaccine Access for Children Under 5
May 20, 2022
May 20, 2022
WASHINGTON, May 20 -- Rep. Chellie Pingree, D-Maine, issued the following news release:
In a House Appropriations Subcommittee on Agriculture, Rural Development, U.S. Food and Drug Administration (FDA), and Related Agencies hearing on Thursday, Congresswoman Chellie Pingree (D-Maine) pressed FDA Commissioner Robert Califf for answers on the FDA's timeline for making the COVID vaccine available to children age 5 and younger.
"I totally understand and appreciate . . .
In a House Appropriations Subcommittee on Agriculture, Rural Development, U.S. Food and Drug Administration (FDA), and Related Agencies hearing on Thursday, Congresswoman Chellie Pingree (D-Maine) pressed FDA Commissioner Robert Califf for answers on the FDA's timeline for making the COVID vaccine available to children age 5 and younger.
"I totally understand and appreciate . . .